SpaceXs Starlink Revenue Drives Growth as Company Eyes Potential Nasdaq Listing Saudi Arabias Vision 2030 Spending Spree Faces Reality Check Top Forecasters Project Inflation to Hit 6 in Q2 Survey Suggests UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Meta Broadcom Among Tech Giants to Fund 125 Million Semiconductor Research Hub at UCLA Federal Reserve Faces Diminishing Case for Rate Cuts as Jobs Data Signals Sticky Inflation Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress Algorhythm Holdings Inc Q1 2026 Earnings Narrowed Loss Beats Estimates but Stock Declines on Revenue Uncertainty Seacoast Banking Corporation of Florida SBCF Q1 2026 Earnings EPS Beats Estimates Amid Steady Net Interest Margin RELL Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Market Sentiment CBZ Q1 2026 Earnings EPS Surpasses Estimates by 124 Shares Edge Higher CSAN Q1 2026 Earnings Heavy Losses as EPS Misses Estimates by a Wide Margin Helix Acquisition Corp III HLXC Holds Steady Near Trust Value Amid Minimal Movement Fox Factory FOXF Rebounds 264 From Support Key Resistance at 1755 in Focus Strategy Inc STRC Preferred Shares Hold Steady Near 9939 Key Levels in Focus Charlton Aria Acquisition Rights CHARR Plunge 3289 to 008 as Selling Pressure Intensifies ASBA Holds Steady at 2475 Subordinated Note Trading in Tight Range Flutter Entertainment FLUT Slides 18 as Selling Pressure Tests Key Support Levels Zevia PBC ZVIA Declines 76 as Shares Test Key Support Zone Illumination Acquisition Corp I Units ILLUU Holds Steady at 999 Amid Quiet Trading Ubiquiti Inc UI Declines 244 Approaching Critical Support After Broad Tech Weakness Avista Corporation AVA Holds Steady Near 4169 as Utility Sector Seeks Direction Lithia Motors LAD Edges Higher Amid Steady Trading Key Levels in Focus Philadelphia Phillies Bryce Harper Comments on Teams Decision to Part Ways with Homegrown Slugger Potential Financial and Roster Implications Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines Rocket Pharmaceuticals Warrant RCKTW Plunges 12 to 001 Amid Thin Trading